Roles of matrix metalloproteinase-7 (MMP-7) in cancer

HY Liao, CM Da, B Liao, HH Zhang - Clinical biochemistry, 2021 - Elsevier
Abstract Matrix metalloproteinase-7 (MMP-7) is a small proteolytic enzyme that secretes zinc
and calcium endopeptidases. It can degrade a variety of extracellular matrix substrates and …

Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer

Z Pezeshkian, S Nobili, N Peyravian, B Shojaee… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) is one of the most common cancer worldwide.
CRC is derived from polyps and many factors, such as Matrix Metalloproteinases (MMPs) …

Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients

F Klupp, L Neumann, C Kahlert, J Diers, N Halama… - BMC cancer, 2016 - Springer
Abstract Background Matrixmetalloproteinases (MMPs) comprise a family of zinc-dependent
endopeptidases which are involved in angiogenesis, tumor invasion and metastatic …

Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer

GP Nagaraju, TE Long, W Park… - Molecular …, 2015 - Wiley Online Library
Epithelial to mesenchymal transition (EMT), invasion, and motility are essential steps in
colorectal cancer (CRC) metastasis regulated by HIF‐1α and NF‐κB. Since HSP90 activates …

Matrix metallopeptidase 3 polymorphisms: emerging genetic markers in human breast cancer metastasis

SA Suhaimi, SC Chan, R Rosli - Journal of breast cancer, 2020 - synapse.koreamed.org
Matrix metallopeptidase 3 or MMP3, is a zinc-dependent proteolytic enzyme that is involved
in various physiological processes via modification of the extracellular matrix. In particular …

Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer

M Vočka, D Langer, V Fryba, J Petrtyl… - … journal of biological …, 2019 - journals.sagepub.com
Objective: Tissue inhibitor of metalloproteinases 1 (TIMP-1) and matrix metalloproteinase 7
(MMP-7) were reported to have potent growth promoting activity. Lack of balance between …

Association of matrix metalloproteinase-2 (MMP-2) and MMP-9 promoter polymorphisms, their serum levels, and activities with coronary artery calcification (CAC) in …

S Elahirad, D Elieh Ali Komi, A Kiani… - Cardiovascular …, 2022 - Springer
The serum levels and activity of matrix metalloproteinases (MMPs) are associated with the
risk of coronary artery calcification (CAC). We sought to investigate the association between …

Matrix metalloproteinases 2 and 9 polymorphism in patients with myeloproliferative diseases: a STROBE-compliant observational study

S Maral, M Acar, OS Balcik, E Uctepe, OF Hatipoglu… - Medicine, 2015 - journals.lww.com
Chronic myeloproliferative disorders such as polycythemia vera (PV), essential
thrombocytosis (ET), and idiopathic myelofibrosis arise from clonal proliferation of neoplastic …

TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke

M Dusanovic Pjevic, B Jekic… - … : The Journal of …, 2021 - Wiley Online Library
Introduction Levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs)
influence recombinant tissue plasminogen activator (rtPA) therapy response in patients with …

[HTML][HTML] Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases

HMCS Kumara, H Miyagaki, SA Herath… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND MMP-2 also known as gelatinase A and MMP-7 (matrilysin) are members of
the zinc-dependent family of MMPs (Matrix metalloproteinase). MMP-2 and MMP-7 are …